Business profile & competitive position
Leidos Holdings, Inc. operates under the Technology sector in the Information Technology Services industry, but its business model sits at the intersection of government contracting, engineered systems, and mission IT. Through its operating subsidiary Leidos, Inc., the company delivers science, research, and engineering solutions across four reportable segments: National Security & Digital (44% of fiscal 2025 revenue), Health & Civil (30%), Commercial & International (13%), and Defense Systems (13%). Offerings range from IT modernization and cyber operations to AI-enabled mission software, managed health services, air traffic systems, energy infrastructure, security detection products, and advanced maritime, aerospace, and land defense systems.
The revenue concentration is striking: approximately 87% of fiscal 2025 revenue came from U.S. government contracts as a prime or subcontractor, while only about 8% came from entities located outside the United States. This makes Leidos less a conventional commercial IT services firm and more a federally focused technology integrator. The margin structure supports that interpretation. A net margin of 7.9% and a return on equity of 27.6% are not the profile of a hardware-heavy prime contractor, but they are also not the high-teens margins seen in pure software. Instead, the figures point to a scalable services and solutions model with moderate capital intensity and strong equity efficiency. Roughly 53% of employees hold U.S. security clearances and 19% are military veterans, reinforcing a labor-based moat centered on cleared talent—an asset that is difficult for outside competitors to replicate quickly.
Financial posture
With a market capitalization of $16.8 billion and a P/E ratio of 12.3, Leidos trades at a noticeable discount to broad technology indices. The net margin of 7.9% and ROE of 27.6% suggest the company converts its government-heavy backlog into solid equity returns without relying on excessive leverage. A beta of 0.57 indicates the stock has historically moved less dramatically than the overall market, which is consistent with the stability implied by long-duration federal contracts.
That valuation juxtaposition is what often draws institutional interest: a mid-teens P/E is typical for slower-growth industrials, yet Leidos is embedded in growth-oriented themes such as cybersecurity, AI-enabled mission software, hypersonic platforms, and digital identity. Its government-services cash flows trade at a discount to commercial IT peers, but the diversified technology stack—from managed health to security detection—commands a premium over pure-play defense primes. The fiscal 2025 R&D outlay of $187 million, or 1.1% of consolidated revenues, is modest by commercial tech standards, reflecting the customer-funded nature of most development work in the federal space.
Strategic priorities & outlook
Leidos's most recent SEC 10-K filing frames five strategic growth pillars: space and maritime; energy infrastructure; digital modernization and cyber; mission software; and managed health services. The company's priorities also include growing the commercial health and infrastructure businesses, executing long-term management initiatives, and responding rapidly to emerging technology trends including artificial intelligence.
Perhaps the clearest near-term operational priority is the completion and integration of Entrust, acquired through KENE Parent, Inc. The deal is aimed at expanding Leidos's credentialing and digital identity footprint, an area that touches both federal and commercial customers. Management has explicitly tied Entrust to its expected benefits, making the integration a measurable milestone for investors tracking execution. Meanwhile, the push to grow commercial health and infrastructure diversifies revenue beyond Washington, although the 87% government revenue share shows that diversification will take time.
Macro & geopolitical exposure
As an Information Technology Services provider with a federal contracting backbone, Leidos is exposed to several macro and geopolitical channels. Federal budget cycles and appropriations decisions directly shape the timing and scale of revenue, since roughly 87% of sales depend on U.S. government spending. Shifts in defense, healthcare, homeland security, and civilian agency priorities can reallocate demand across the company's segments.
Regulation, data-security requirements, and export controls matter because sensitive programs require cleared facilities and personnel. International revenue, at around 8%, introduces currency and cross-border compliance considerations, while supply-chain constraints can affect defense systems and security detection hardware. The company is also tied to the aerospace, maritime, and energy infrastructure end markets, all of which carry capital-project and commodity-price sensitivities. Rising or falling government investment in cyber modernization, AI, and hypersonic capabilities would be particularly consequential given Leidos's strategic positioning around those themes.
Recent developments
Recent headlines have kept Leidos in front of growth-oriented investors. On 2026-09-12, defenseworld.net reported that Amundi Acquires 14,049 Shares of Leidos Holdings, Inc. ($LDOS), signaling continued institutional accumulation. On 2026-09-11, Zacks published "Here's Why Leidos (LDOS) is a Strong Growth Stock," and on 2026-09-10 the same outlet ran two pieces: "Leidos (LDOS) Increases Despite Market Slip: Here's What You Need to Know" and "Can Hypersonic Weapons Production Boost Leidos' Growth Prospects?" Collectively, the news flow points to market interest around both the company's relative strength and specific program opportunities such as hypersonic weapons.
Earnings behavior & post-earnings drift
Leidos has delivered an unusually consistent earnings track record. Over the last eight reported quarters, the company beat the official consensus every time, for a beat rate of 8 out of 8, or 100%. The average earnings surprise across those quarters was 16%, a meaningful gap that suggests the market's real expectation may sit below the published consensus or that management's guidance has remained conservative.
The post-earnings drift has been classified as "up," with an average 5-day move of 2.15% in the trading days following each report. The most recent quarter, reported on 2026-08-04, is a good example of the pattern: actual EPS came in at $3.26 versus an estimate of $2.91, a 12% beat, yet the stock fell 2.87% the next day before rallying 7.88% over the following five days. That sequence of a negative immediate reaction followed by a positive drift also appeared after the 2026-02-17 report, which beat by 5.7% and posted a next-day gain of 6.19% before rising 7.8% over five sessions.
Not every quarter followed the same script. The 2026-05-05 report beat by 7.9% but saw the stock decline 1.67% the next day and 6.41% over the next five days. The 2025-11-04 report beat by 12.5% and declined 2.25% the next day and 0.65% over five days. These exceptions highlight that beating estimates has not guaranteed short-term upside, but the average tendency across the full eight-quarter sample has been a modest upward drift.
Leidos is next scheduled to report on 2026-11-03 before the market open. The current consensus EPS estimate is $3.00.
Frequently Asked Questions
What does Leidos actually do?
Leidos is a science, engineering, and IT services company organized into four segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Its work spans cyber operations, AI-enabled mission software, managed health services, air traffic systems, energy infrastructure, security detection, and advanced defense systems. About 87% of revenue comes from U.S. government contracts.
How has Leidos performed around earnings?
Over the last eight reported quarters, Leidos has beaten the consensus EPS estimate every time, with an average surprise of 16%. The average 5-day price move after those reports has been 2.15% to the upside, classified as an upward post-earnings drift, though individual quarters have varied.
What are Leidos's main strategic priorities?
According to its most recent 10-K filing, Leidos is focused on five growth pillars—space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health services—along with integrating the Entrust acquisition and expanding its commercial health and infrastructure businesses.
For a deeper dive into how institutional investors are currently weighing these government services, cyber, and defense technology dynamics, readers should explore the full institutional verdict and consensus outlook for Leidos.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-04 | $3.26 | $2.91 | +12% | -2.87% | +7.88% |
| 2026-05-05 | $3.13 | $2.9 | +7.9% | -1.67% | -6.41% |
| 2026-02-17 | $2.76 | $2.61 | +5.7% | +6.19% | +7.8% |
| 2025-11-04 | $3.05 | $2.71 | +12.5% | -2.25% | -0.65% |
| 2025-08-05 | $3.21 | $2.66 | +20.7% | - | - |
| 2025-05-06 | $2.97 | $2.5 | +18.8% | - | - |
Previous LDOS editions
Get the institutional verdict on LDOS
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the LDOS verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.